Cargando…

Altered tissue oxygenation in patients with post COVID-19 syndrome

BACKGROUND: Post COVID-19 syndrome (PCS) is a complex condition with partly substantial impact on patients' social and professional life and overall life quality. Currently, the underlying cause(s) of PCS are unknown. Since PCS-specific symptoms could be associated with systemic alterations in...

Descripción completa

Detalles Bibliográficos
Autores principales: Schäfer, Hendrik, Teschler, Marc, Mooren, Frank C., Schmitz, Boris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188192/
https://www.ncbi.nlm.nih.gov/pubmed/37201676
http://dx.doi.org/10.1016/j.mvr.2023.104551
_version_ 1785042864665788416
author Schäfer, Hendrik
Teschler, Marc
Mooren, Frank C.
Schmitz, Boris
author_facet Schäfer, Hendrik
Teschler, Marc
Mooren, Frank C.
Schmitz, Boris
author_sort Schäfer, Hendrik
collection PubMed
description BACKGROUND: Post COVID-19 syndrome (PCS) is a complex condition with partly substantial impact on patients' social and professional life and overall life quality. Currently, the underlying cause(s) of PCS are unknown. Since PCS-specific symptoms could be associated with systemic alterations in tissue oxygen supply, we aimed to investigate changes in tissue oxygenation in patients with PCS. METHODS: A case-control study including 30 PCS patients (66.6 % males, 48.6 ± 11.2 years, mean time after (first) acute infection: 324 days), 16 cardiologic patients (CVD) (65.5 % males, 56.7 ± 6.3 years) and 11 young healthy controls (55 % males, 28.5 ± 7.4 years) was conducted. Near infrared spectroscopy (NIRS) was used to assess changes in tissue oxygenation during an arterial occlusion protocol on the non-dominant forearm (brachioradialis, 760/850 nm, 5 Hz). The protocol included 10-min rest, a 2-min baseline measurement followed by a 3-min ischemic period (upper-arm cuff, 50 mmHg above resting systolic blood pressure) and a 3-min reoxygenation period. PCS patients were grouped by presence of arterial hypertension and elevated BMI to assess the impact of risk factors. RESULTS: No differences in mean tissue oxygenation in the pre-occlusion phase existed between groups (p ≥ 0.566). During ischemia, comparisons of linear regressions slopes revealed slower oxygen desaturation for PCS patients (−0.064 %/s) compared to CVD patients (−0.08 %/s) and healthy subjects (−0.145 %/s) (p < 0.001). After cuff release, slowest speed for reoxygenation was detected in PCS patients at 0.84 %/s compared to CVD patients (1.04 %/s) and healthy controls (CG: 2.07 %/s) (p < 0.001). The differences between PCS patients and CVD patients during ischemia remained significant also after correction for risk factors. Analyses of complications during acute infection, persistence of PCS symptoms (time after acute infection), or PCS severity (number of lead symptoms) as confounding factors did not reveal a significant effect. CONCLUSIONS: This study provides evidence that the rate of tissue oxygen consumption is persistently altered in PCS and that PCS patients show an even slower decline in tissue oxygenation during occlusion than CVD patients. Our observations may at least partly explain PCS-specific symptoms such as physical impairment and fatigue.
format Online
Article
Text
id pubmed-10188192
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-101881922023-05-17 Altered tissue oxygenation in patients with post COVID-19 syndrome Schäfer, Hendrik Teschler, Marc Mooren, Frank C. Schmitz, Boris Microvasc Res Short Communication BACKGROUND: Post COVID-19 syndrome (PCS) is a complex condition with partly substantial impact on patients' social and professional life and overall life quality. Currently, the underlying cause(s) of PCS are unknown. Since PCS-specific symptoms could be associated with systemic alterations in tissue oxygen supply, we aimed to investigate changes in tissue oxygenation in patients with PCS. METHODS: A case-control study including 30 PCS patients (66.6 % males, 48.6 ± 11.2 years, mean time after (first) acute infection: 324 days), 16 cardiologic patients (CVD) (65.5 % males, 56.7 ± 6.3 years) and 11 young healthy controls (55 % males, 28.5 ± 7.4 years) was conducted. Near infrared spectroscopy (NIRS) was used to assess changes in tissue oxygenation during an arterial occlusion protocol on the non-dominant forearm (brachioradialis, 760/850 nm, 5 Hz). The protocol included 10-min rest, a 2-min baseline measurement followed by a 3-min ischemic period (upper-arm cuff, 50 mmHg above resting systolic blood pressure) and a 3-min reoxygenation period. PCS patients were grouped by presence of arterial hypertension and elevated BMI to assess the impact of risk factors. RESULTS: No differences in mean tissue oxygenation in the pre-occlusion phase existed between groups (p ≥ 0.566). During ischemia, comparisons of linear regressions slopes revealed slower oxygen desaturation for PCS patients (−0.064 %/s) compared to CVD patients (−0.08 %/s) and healthy subjects (−0.145 %/s) (p < 0.001). After cuff release, slowest speed for reoxygenation was detected in PCS patients at 0.84 %/s compared to CVD patients (1.04 %/s) and healthy controls (CG: 2.07 %/s) (p < 0.001). The differences between PCS patients and CVD patients during ischemia remained significant also after correction for risk factors. Analyses of complications during acute infection, persistence of PCS symptoms (time after acute infection), or PCS severity (number of lead symptoms) as confounding factors did not reveal a significant effect. CONCLUSIONS: This study provides evidence that the rate of tissue oxygen consumption is persistently altered in PCS and that PCS patients show an even slower decline in tissue oxygenation during occlusion than CVD patients. Our observations may at least partly explain PCS-specific symptoms such as physical impairment and fatigue. Elsevier Inc. 2023-07 2023-05-16 /pmc/articles/PMC10188192/ /pubmed/37201676 http://dx.doi.org/10.1016/j.mvr.2023.104551 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Schäfer, Hendrik
Teschler, Marc
Mooren, Frank C.
Schmitz, Boris
Altered tissue oxygenation in patients with post COVID-19 syndrome
title Altered tissue oxygenation in patients with post COVID-19 syndrome
title_full Altered tissue oxygenation in patients with post COVID-19 syndrome
title_fullStr Altered tissue oxygenation in patients with post COVID-19 syndrome
title_full_unstemmed Altered tissue oxygenation in patients with post COVID-19 syndrome
title_short Altered tissue oxygenation in patients with post COVID-19 syndrome
title_sort altered tissue oxygenation in patients with post covid-19 syndrome
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188192/
https://www.ncbi.nlm.nih.gov/pubmed/37201676
http://dx.doi.org/10.1016/j.mvr.2023.104551
work_keys_str_mv AT schaferhendrik alteredtissueoxygenationinpatientswithpostcovid19syndrome
AT teschlermarc alteredtissueoxygenationinpatientswithpostcovid19syndrome
AT moorenfrankc alteredtissueoxygenationinpatientswithpostcovid19syndrome
AT schmitzboris alteredtissueoxygenationinpatientswithpostcovid19syndrome